Kimberly Brannen, PhD

Principal Scientist, Merck
West Point, PA
USA

Kimberly is a developmental and reproductive toxicology study director supporting drug discovery and development programs. Prior to joining Merck in 2015, she was a Reproductive Toxicology Study Director at Charles River’s Safety Assessment site in Horsham, PA. Her training is in developmental toxicology, and she has particular interests in the use of alternative models, including zebrafish.